Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BUPROPION HYDROCHLORIDE USP, with a corresponding US DMF Number 18163.
Remarkably, this DMF maintains an Active status since its submission on March 14, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 15, 2014, and payment made on May 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II